Blinded Randomized Trial of Anticoagulation to Prevent Ischemic Stroke and Neurocognitive Impairment in AF

PHASE3TerminatedINTERVENTIONAL
Enrollment

1,238

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

May 18, 2024

Study Completion Date

May 18, 2024

Conditions
ATRIAL FIBRILLATION
Interventions
DRUG

Rivaroxaban

15 mg

OTHER

standard of care

Trial Locations (41)

Unknown

CardiAi Inc., Calgary

Libin Cardiovascular Institute of Alberta, Calgary

University of Alberta, Edmonton

North Shore Heart Center, North Vancouver

Vancouver General Hospital/UBC, Vancouver

Cardio 1, Winnipeg

St. Boniface Hospital, Winnipeg

Dr. Georges-L - Dumont University Hospital Center, Moncton

QEll Health Sciences Center-Halifax Infirmary, Halifax

Western University - London Health Sciences Centre, London

PACE (Partners in Advanced Cardiac Evaluation), Newmarket

Oakville Cardiovascular Research LP, Oakville

Cambridge Cardiac Care Center, Cambridge

Vizel Cardiac Research, Cambridge

Hamilton Health Sciences - General Site, Hamilton

McMaster University, Hamilton

Cardiology Clinic, Kitchener

St. Mary's general Hospital, Kitchener

One Heart Care, Mississauga

University of Ottawa Heart Institute, Ottawa

St. Michael's Hospital, Toronto

Viacar Recherche Clinique Inc., Brossard

CIUSSS du Saguenay-Lac-Saint-Jean, Chicoutimi

CIUSSS de l'Estrie-CHUS-Centre Haute-Yamaska (Hopital de Granby), Granby

CISSSMC-Hopital Charles-Lemoyne, Greenfield Park

Viacar Recherche Clinique Inc., Greenfield Park

Hopital de la Cite-de-la-Sante, Laval

Clinique Cardiologie de Levis, Lévis

CHUM, Montreal

Hopital du Sacre Coeur de Montreal, Montreal

McGill University Health Center, Montreal

Montreal Heart Institute, Montreal

CISSS BSL-Hopital de Rimouski, Rimouski

CISSS des Laurentides-Unite de recherche clinique, Saint-Jérôme

CIUSSS de l'Estrie-CHUS, Sherbrooke

CISSS de Lanaudiere-Hopital Pierre-Le Gardeur, Terrebonne

CIUSSS MCQ CHAUR- Centre Hospitalier regional de Trois-Rivieres, Trois-Rivières

CHU de Quebec-Universite Laval/Hotel Dieu de Quebec, Québec

Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Québec

V5Z 1M9

Office of Dr. TunZan Maung, MD, Abbotsford

H1T1C8

Montreal Heart Institute, Montreal

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Canadian Stroke Prevention Intervention Network

OTHER

collaborator

The Montreal Health Innovations Coordinating Center (MHICC)

OTHER

collaborator

Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

INDUSTRY

collaborator

Montreal Heart Institute Foundation

UNKNOWN

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Hewitt Foundation

UNKNOWN

lead

Montreal Heart Institute

OTHER